What is ACIXF stock price today?

ACIXF (Acarix AB (publ)) stock is trading at $0.03 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACIXF stock going up or down today?

ACIXF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACIXF stock now?

The decision to buy ACIXF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACIXF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACIXF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACIXF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACIXF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACIXF's P/E ratio?

P/E ratio data for ACIXF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACIXF's market cap?

ACIXF (Acarix AB (publ)) has a market capitalization of $0.04 billion, making it a small-cap stock.

What is ACIXF's price to book ratio?

ACIXF trades at a price-to-book (P/B) ratio of 7.88, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACIXF pay dividends?

ACIXF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACIXF's dividend yield?

ACIXF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACIXF stock a good long-term investment?

ACIXF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACIXF's revenue growth rate?

ACIXF has shown revenue growth of 1.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for ACIXF are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACIXF?

Key risks for ACIXF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACIXF compare to its competitors?

Compare ACIXF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACIXF's performance and positioning.

What is ACIXF's stock price target for 2026?

Our AI model provides price targets for ACIXF based on fundamental analysis: Bull case $0.04 (+30%), Base case $0.03 (+15%), Bear case $0.03 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACIXF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACIXF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACIXF's next earnings report?

ACIXF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACIXF - Acarix AB (publ)

NYSE * Healthcare * Medical Devices

$0.03

+$0.00 (+0.00%)

About Acarix AB (publ)

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

ACIXF Key Statistics

Market Cap

$36.42M

P/B Ratio

7.88

Revenue Growth

+1.4%

Employees

How ACIXF Compares to Peers

ACIXF has the fastest revenue growth among competitors

ACIXF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACIXF(This stock)	$36.42M	N/A	1%	0.0%	-
ABTAbbott Laboratories	$210.84B	15.2	0%	0.3%	vs ABT
MDTMedtronic Plc	$126.47B	26.7	0%	0.1%	vs MDT
SYKStryker Corp	$137.52B	47.2	0%	0.1%	vs SYK
BSXBoston Scientific	$135.25B	48.8	0%	0.1%	vs BSX
ISRGIntuitive Surgical	$189.07B	70.0	0%	0.3%	vs ISRG

Acarix AB (publ) Company Information

Headquarters: Regus MalmOe, Malmö, Sweden, 215 32, undefined
Website: www.acarix.com
Sector: Healthcare
Industry: Medical Devices

Data Updated: January 21, 2026 at 5:15 AM EST

Ready to invest in ACIXF?

Commission-free trading available. Affiliate links.

Upcoming Events for ACIXF

Dashboard

Enter a ticker to analyze